MENU

ALT Altimmune Forecast, Technical & Fundamental Analysis

Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases... Show more

ALT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
ALT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ALT is expected to report earnings to rise 13.00% to -13 cents per share on November 10

Altimmune ALT Stock Earnings Reports
Q3'26
Est.
$-0.14
Q2'26
Beat
by $0.03
Q1'26
Beat
by $0.06
Q4'25
Missed
by $0.02
Q3'25
Beat
by $0.06
The last earnings report on August 12 showed earnings per share of -11 cents, beating the estimate of -15 cents. With 4.20M shares outstanding, the current market capitalization sits at 604.95M.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceuticals

Industry Biotechnology

Profile
Details
Industry
Miscellaneous Commercial Services
Address
910 Clopper Road
Phone
+1 240 654-1450
Employees
57
Web
https://www.altimmune.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HRNIX21.890.20
+0.92%
Hood River New Opportunities Investor
CSSYX28.930.24
+0.84%
Columbia Select Small Cap Value Inst3
RGBCX43.190.21
+0.49%
American Funds Global Balanced R-3
CMSHX40.970.17
+0.42%
Columbia Small Cap Growth S
ECFGX19.610.08
+0.41%
Eaton Vance Focused Growth Opps C

ALT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ALT has been loosely correlated with OGEN. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ALT jumps, then OGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALT
1D Price
Change %
ALT100%
+5.42%
OGEN - ALT
54%
Loosely correlated
-2.78%
ACHV - ALT
45%
Loosely correlated
-0.37%
INDP - ALT
45%
Loosely correlated
-6.52%
DNLI - ALT
41%
Loosely correlated
-0.12%
RXRX - ALT
41%
Loosely correlated
+4.79%
More
Altimmune (ALT) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com